| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |